Howard S. Hochster, MD, discusses the importance of clinical trial participation for patients with cancer and highlights the use of precision medicine across the treatment armamentarium.
Howard S. Hochster, MD, FACP
Advertisement
Articles by Howard S. Hochster, MD, FACP
Howard S. Hochster, MD, FACP, discusses treatment considerations for patients with HER2-positive gastric cancer.
Howard S. Hochster, MD, FACP, discusses important takeaways from the randomized, double-blind, phase III POLO trial in pancreatic cancer.
Advertisement
Latest Updated Articles
Dr. Hochster on Take-Home Message of the POLO Trial in Pancreatic CancerPublished: October 2nd 2019 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
2
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
3
Anti–Gremlin-1 Therapy Plus Chemo Makes Waves in GI Malignancies
4
FDA Grants Fast Track Designation to IBI3003 in Relapsed/Refractory Multiple Myeloma
5